Kuva Labs ends Lisata tender offer after financing falls through

Kuva Labs said it could not secure the financing needed to complete its planned tender offer for Lisata Therapeutics, and the offer expired without an extension on July 20, 2026. Tendered shares are being returned to stockholders, and Kuva says it still wants to pursue a deal with Lisata.

Why it matters: - The collapse of the financing removes Kuva Labs’ immediate path to acquire all outstanding shares of Lisata Therapeutics. - Lisata stockholders who tendered shares will get them back, ending the pending transaction for now. - Kuva Labs still wants a transaction with Lisata, so the deal may not be off the table entirely.

What happened: - Kuva Labs Inc. said it and its wholly owned subsidiary, Kuva Acquisition Corp., could not complete the financing needed for the planned tender offer for Lisata Therapeutics, Inc. - The offer was intended to acquire all outstanding shares of Lisata common stock. - Kuva sought an extension, but the offer expired at 11:59 p.m. New York City time on July 20, 2026, without one being granted. - Because the financing was not obtained, the offer will not be consummated.

The details: - Kuva instructed Equiniti Trust Company, LLC, the depositary for the offer, to return all tendered shares that were not withdrawn. - The return applies to shares tendered as of July 24, 2026. - Tendering stockholders do not need to take any action. - Lisata trades on Nasdaq under the ticker LSTA.

Between the lines: - The announcement signals a financing failure, not a strategic retreat from interest in Lisata. - Kuva’s continued interest suggests future negotiations could still happen if financing or deal terms change. - The expiration without an extension likely resets the process and leaves Lisata independent for now.

What's next: - Equiniti is handling the return of tendered shares to stockholders. - Any renewed transaction effort would require new financing and a new deal process. - Kuva Labs may continue discussions with Lisata if both sides choose to move forward.